fampridine accord
accord healthcare s.l.u. - fampridine - išsėtinė sklerozė - kiti nervų sistemos vaistai - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).
kesimpta
novartis ireland ltd - ofatumumab - išsėtinė sklerozė, grįžtamoji-pervedimo - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
ponvory
janssen-cilag international n.v. - ponesimod - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
fingolimod mylan
mylan ireland limited - fingolimod hidrochloridas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ir 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantais, pasirinktinio imunosupresantais - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
alfuzosin-teva
teva pharma b.v. - alfuzozinas - pailginto atpalaidavimo tabletės - 10 mg - alfuzosin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 500 mg - metformin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 750 mg - metformin
tivulin
berlin-chemie ag - metformino hidrochloridas - pailginto atpalaidavimo tabletės - 1000 mg - metformin